SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
Vera Therapeutics, Inc.
@VERA_InsiderForm 4 Filing: Fordyce Marshall Sells $701,769.253 of $VERA
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Vera Therapeutics, Inc.
Ticker: $VERA
Transaction Value
$701,769.253
Price/Share: $37.93
transaction date
2026-06-23
Shares: 18,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Fordyce Marshall, holds the title of PRESIDENT AND CEO at Vera Therapeutics, Inc..
On 2026-06-23, the insider transacted 18,500 shares.The shares were transacted at a weighted average price of $37.93 per share, resulting in a total market-relevant value of $701,769.253.
Executive Summary Summary
Fordyce Marshall (PRESIDENT AND CEO) sold $702K of $VERA
Post-Transaction Position: 198,332 shares
SEC Accession No: 0001859453-26-000008 (CIK: 1859453)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.